Dr. Fisher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
875 blake wilbur drive
Stanford, CA 94305Phone(650) 725-9057Fax(650) 498-5353- Is this information wrong?
Education & Training
- Stanford Health CareFellowship, Medical Oncology, 1990 - 1993
- Stanford Health CareResidency, Internal Medicine, 1987 - 1989
- Stanford University School of MedicineClass of 1987
Certifications & Licensure
- CA State Medical License 1989 - 2023
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors Start of enrollment: 2012 Dec 01
- Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C) Start of enrollment: 2013 Sep 01
- Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody Start of enrollment: 2014 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancer.Olga Generalova, Mohana Roy, Evan T. Hall, Sumit A. Shah, Kristen M. Cunanan, Touran Fardeen, Brianna Velazquez, Gilbert Chu, Bianca Bruzzone, Anna Cabot, George A. Fi...> ;Journal of Patient-Reported Outcomes. 2021 Sep 15
- Durable response after immune checkpoint inhibitor-related diabetes in mismatch repair-deficient pancreatic cancer.Erica S Tsang, Evan J. Walker, Julia Carnevale, George A. Fisher, Andrew H. Ko> ;Immunotherapy. 2021 Aug 2
- Pancreatic INI1-deficient undifferentiated rhabdoid carcinoma achieves complete clinical response on gemcitabine and nab-paclitaxel following immediate progression on ...Daniel A King, Smruti Rahalkar, David B. Bingham, George A. Fisher> ;Journal of gastrointestinal oncology. 2021 Apr 1
- Join now to see all
Lectures
- A phase Ib/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
- Using Molecular Diagnostics Across the Cancer Care Continuum to Enhance the Care of Esophageal and Gastric CancerASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
- 9th Annual Meeting of International Society of Gastrointestinal OncologyInternational Society of Gastrointestinal Oncology (ISGIO), Arlington, Virginia - 9/13/2012
Hospital Affiliations
- Stanford Health CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: